Britannica
Sources used in this answer
How does pharmacogenomics use DNA sequences to guide treatment choices?
Created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
bioinformatics
This computerized image of anthrax shows the various structural relationships of seven units within the protein and demonstrates the interaction of a drug (shown in yellow) bound to the protein to block the so-called lethal factor unit. Bioinformatics plays an important role in enabling scientists to predict where a drug molecule will bind within a protein, given the individual structures of the molecules.
Pharmacogenomics is a field of science that examines how genetic variations influence an individual's response to drugs, allowing for the development of therapies tailored to a patient's specific genetic makeup. Within the context of bioinformatics, this process uses DNA sequences to guide treatment choices in several key ways:12
- Identifying Genetic Variations: Bioinformatics tools analyze genomic data to identify specific variations, such as single nucleotide polymorphisms (SNPs), which are differences in a single building block of DNA. These variations can alter how a person metabolizes or responds to a medication.3
- Predicting Drug Response: By screening a patient's genome for these specific markers, physicians can predict whether a drug will be effective or if it might cause severe side effects. This helps in selecting the most appropriate drug and determining the correct dosage to achieve the desired therapeutic effect while avoiding toxicity.23
- Targeted Therapy: In conditions like cancer, bioinformatics helps identify specific molecular targets—such as mutated enzymes—allowing for the use of drugs designed to interact precisely with those targets.2
Ultimately, this approach shifts medicine away from a "one-size-fits-all" strategy toward personalized medicine, where treatment is optimized based on an individual's unique genetic constitution.23